ZA978921B - Therapeutic use of hemoglobin to treat head injury. - Google Patents

Therapeutic use of hemoglobin to treat head injury.

Info

Publication number
ZA978921B
ZA978921B ZA9708921A ZA978921A ZA978921B ZA 978921 B ZA978921 B ZA 978921B ZA 9708921 A ZA9708921 A ZA 9708921A ZA 978921 A ZA978921 A ZA 978921A ZA 978921 B ZA978921 B ZA 978921B
Authority
ZA
South Africa
Prior art keywords
hemoglobin
therapeutic use
head injury
treat head
treat
Prior art date
Application number
ZA9708921A
Other languages
English (en)
Inventor
Kenneth E Burhop
Steven R Shackford
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of ZA978921B publication Critical patent/ZA978921B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA9708921A 1996-10-21 1997-10-06 Therapeutic use of hemoglobin to treat head injury. ZA978921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73429696A 1996-10-21 1996-10-21

Publications (1)

Publication Number Publication Date
ZA978921B true ZA978921B (en) 1998-04-17

Family

ID=24951094

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708921A ZA978921B (en) 1996-10-21 1997-10-06 Therapeutic use of hemoglobin to treat head injury.

Country Status (7)

Country Link
US (1) US6046170A (xx)
EP (1) EP1007062A4 (xx)
JP (1) JP2001502351A (xx)
AU (1) AU4661797A (xx)
CA (1) CA2268517A1 (xx)
WO (1) WO1998017289A1 (xx)
ZA (1) ZA978921B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709873B1 (en) * 1997-04-09 2004-03-23 Isodiagnostika Inc. Method for production of antibodies to specific sites of rapamycin
EP2292657A1 (en) 1999-11-12 2011-03-09 Baxter Biotech Technology S.A.R.L. Reduced side-effect hemoglobin compositions
DE10059720A1 (de) * 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
CA3070172A1 (en) 2017-07-18 2019-01-24 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
GB8328917D0 (en) * 1983-10-28 1983-11-30 Fisons Plc Blood substitute
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
US4994444A (en) * 1987-07-31 1991-02-19 The Trustees Of Columbia In The City Of New York Macromolecules for sealing capillary endothelial junctions
US5386014A (en) * 1989-11-22 1995-01-31 Enzon, Inc. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
US5439882A (en) * 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
US5382680A (en) * 1990-12-07 1995-01-17 The Center For Innovative Technology Allosteric hemoglobin modifier compounds
US5290803A (en) * 1990-02-12 1994-03-01 The Center Of Innovative Technology Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
WO1996029346A1 (en) * 1995-03-23 1996-09-26 Biopure Corporation Stable polymerized hemoglobin blood-substitute
WO1996032130A1 (en) * 1995-04-10 1996-10-17 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage

Also Published As

Publication number Publication date
AU4661797A (en) 1998-05-15
CA2268517A1 (en) 1998-04-30
EP1007062A1 (en) 2000-06-14
JP2001502351A (ja) 2001-02-20
WO1998017289A1 (en) 1998-04-30
EP1007062A4 (en) 2002-10-02
US6046170A (en) 2000-04-04

Similar Documents

Publication Publication Date Title
PL333284A1 (en) Methods for medicinal treatment of skin pigmentation
HUP0103839A3 (en) Use of certain drugs for treating nerve root injury
ZA952356B (en) Skin treatment composition
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
EP0892632A4 (en) AGENTS FOR USE IN PHOTOTHERAPEUTIC TREATMENT OF PROLIFERATIVE SKIN DISORDERS
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
PL336760A1 (en) Treatment of skin diseases
GB2355196B (en) Companion animal therapeutic treat
ZA978921B (en) Therapeutic use of hemoglobin to treat head injury.
ZA968054B (en) Therapeutic use of hemoglobin in promoting wound healing
ZA952121B (en) Skin treatment composition
GB9222260D0 (en) Skin treatment
IL131347A0 (en) Treatment of skin disorders
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
ZA952120B (en) Skin treatment composition
EP1009236A4 (en) EVALUATION, ADMINISTRATION AND USE OF MEANS FOR THE TREATMENT OF HEART DISEASES
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
HU9700079D0 (en) Topical compositions for the treatment of skin disease
SI0928193T1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
AU1355095A (en) Pharmaceutcal agents for the treatment of myocardial reperfusion injury and myocardial stunning
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
GB9608572D0 (en) Improvements relating to patient treatment
GB9218773D0 (en) Skin treatment
ZA9610134B (en) The use of 1-hydroxy-2-pyridones for the treatment of mucosal disorders which are difficult to treat
GB9815188D0 (en) Treatment of skin disorders